Latest Breaking News On - Targeted sustained therapy - Page 1 : comparemela.com

Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.

Sia daneshmandPretzel deviceOsmotic pumpSunrise 1Sunrise 2Sunrise 3Sunrise 4Pd 1Mechanisms of releaseTar 210Targeted sustained therapySustained releaseGlobal trialsTar 200Chromatin regulators crs